E. Alonso

ORCID: 0009-0003-3984-549X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Advanced Radiotherapy Techniques
  • Lung Cancer Diagnosis and Treatment
  • Advances in Oncology and Radiotherapy
  • Head and Neck Cancer Studies
  • Management of metastatic bone disease
  • Breast Cancer Treatment Studies
  • Brain Metastases and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Dysphagia Assessment and Management
  • Esophageal and GI Pathology
  • Blood Pressure and Hypertension Studies
  • Effects of Radiation Exposure
  • Medical Imaging and Pathology Studies
  • Cardiovascular Function and Risk Factors
  • Cancer Diagnosis and Treatment
  • Breast Implant and Reconstruction
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer and Skin Lesions
  • Patient Safety and Medication Errors
  • Tuberculosis Research and Epidemiology
  • Stress and Burnout Research
  • IgG4-Related and Inflammatory Diseases
  • Thyroid Cancer Diagnosis and Treatment
  • Erythropoietin and Anemia Treatment
  • Breast Lesions and Carcinomas

Vicomtech
2024

University of the Basque Country
2024

Hospital Universitario de La Princesa
2019

Hospital Universitario Puerto Real
2017

Guy's and St Thomas' NHS Foundation Trust
2017

St Thomas' Hospital
2017

Hospital Universitario Puerta del Mar
2000-2016

Hôpital Albert-Chenevier
2009-2010

Hospital Geral de Bonsucesso
2004

Hospital Clínico Universitario Lozano Blesa
1989

This paper presents a novel approach for screening women in their first trimester of pregnancy to identify those at high risk having child with Down syndrome (DS), using machine learning algorithms. Various models, including statistical, linear, and ensemble were trained pseudo-anonymized dataset 90,532 patients. dataset, containing less than 1% positive cases, was obtained from Cruces University Hospital, public health hospital (Osakidetza) Baracaldo, Basque Country, Spain. The models...

10.3390/app15105401 article EN cc-by Applied Sciences 2025-05-12

Introduction:Radiotherapy has proven to be an effective treatment when used alone or with other therapies. However, underuse of radiotherapy been observed in various studies. The objective this investigation was assess the use as initial for lung cancer a southern region Europe.Methods:A systematic review guidelines and observational studies performed estimate expected radiation rates associated survival outcomes. We then reviewed clinical records all patients undergoing during 2007 12...

10.1097/jto.0b013e3182745640 article EN publisher-specific-oa Journal of Thoracic Oncology 2012-11-17

Lung cancer remains one of the most prevalent forms cancer. Radiotherapy, with or without other therapeutic modalities, is an effective treatment. Our objective was to report on use radiotherapy for lung cancer, its variability in our region, and compare results previous study done 2004 (VARA-I) region published data. We reviewed clinical records treatment sheets all patients undergoing during 2007 12 public hospitals Andalusia, autonomous Spain. Data were gathered hospital, patient type...

10.1186/1471-2407-14-697 article EN cc-by BMC Cancer 2014-09-23

Metastases are detected in 20% of patients with solid tumours at diagnosis and a further 30% after diagnosis. Radiation therapy (RT) has proven effective bone (BM) brain (BrM) metastases. The objective this study was to analyze the variability RT utilization rates clinical practice accessibility medical technology our region. We reviewed records treatment sheets all undergoing for BM and/or BrM during 2007 12 public hospitals an autonomous region Spain. Data were gathered on hospital type,...

10.1186/1748-717x-7-131 article EN cc-by Radiation Oncology 2012-08-03

The most well-established risk factor for lung cancer (LC) is smoking, responsible approximately 85% of cases. Lung Cancer Risk Assessment Tool (LCRAT) a key advancement in this field, which predicts individual based on factors like smoking habits, demographic details, personal and family medical history, environmental exposures. This paper proposes model with fewer features that improves state the art performance, using simplified stacking ensemble, making it more accessible easier to...

10.3233/shti241083 article EN cc-by-nc Studies in health technology and informatics 2024-11-22

incidencia de anemia antes y durante la irradiación secundariamente influencia del tratamiento en corrección misma según el momento su aparición.

10.4321/s0378-48352004000900002 article ES Oncología (Barcelona) 2004-09-01

10.1016/j.rpor.2013.03.312 article EN publisher-specific-oa Reports of Practical Oncology & Radiotherapy 2013-06-01

Conclusion:In the majority of patients with symptomatic primary or recurrent RC, PPRT 30-39 Gy contributes to relief pain, rectal dysfunction, hematochezia, and other pelvic symptoms, little toxicity.A large proportion prescribed RC have very limited life expectancy future studies should investigate patient selection further simplification PPRT.

10.1016/s0167-8140(16)32031-x article EN cc-by-nc-nd Radiotherapy and Oncology 2016-04-01

10.1016/j.rpor.2013.03.409 article EN publisher-specific-oa Reports of Practical Oncology & Radiotherapy 2013-06-01
Coming Soon ...